Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Curran (Lexington, United States of America), C. Charron (London, United Kingdom), P. Russell (London, United Kingdom), D. Hava (Lexington, United States of America). PUR1800 (RV1162), A novel narrow spectrum kinase inhibitor, but not Fluticasone, reduces TNFa-induced cytokine release by primary bronchial epithelial cells from healthy volunteers and COPD patients. 5247

Member's Comments

No comment yet.

Related content which might interest you: Chemokine release in response to Streptococcus pneumoniae, by primary bronchial epithelial cells of patients with severe asthma and healthy controls Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma Year: 2009 The dissociated steroid receptor ligand from plant origin called compound A (CpdA) inhibits the production of steroid-resistant chemokines induced by TNFα/IFNγ in airway smooth muscle (ASM) cells in both asthma and healthy subjects Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung Year: 2012 The pan janus kinase (JAK) inhibitor KN-002 suppresses inflammatory mediator release from severe asthma bronchial epithelial cells. Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 The influence of gluco-corticoids (GC) on the apoptosis of activated cells in the induced sputum of patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 384s Year: 2002 Novel narrow spectrum kinase inhibitors inhibit rhinovirus replication via enhancement of interferon expression in nasal epithelial cells of atopic and non-atopic patients Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections Year: 2011 The regulation of apoptosis in the induced sputum cells of patients with bronchial asthma (BA) using different therapeutic programms Source: Eur Respir J 2003; 22: Suppl. 45, 79s Year: 2003 Fluticasone reduces IL-6 and IL-8 production of cystic fibrosis bronchial epithelial cells via IKK-β kinase pathway Source: Eur Respir J 2003; 21: 574-581 Year: 2003 Inhibitory activity of fluticasone propionate (FP), on the constitutive or cytokine-induced bronchial epithelial cell (HBECs) functions in vitro Source: Eur Respir J 2003; 22: Suppl. 45, 76s Year: 2003 Fluticasone induces apoptosis in peripheral T-lymphocytes: a comparison between asthmatic and normal subjects Source: Eur Respir J 2002; 19: 257-266 Year: 2002 Aminoguanidine inhibits bronchial NO production, but not diffusion or alveolar NO in patients with asthma, smokers and healthy volunteers Source: Eur Respir J 2004; 24: Suppl. 48, 577s Year: 2004 TD-0903, an inhaled JAK inhibitor in development for COVID-19, blocks ARDS-relevant hyperinflammation and lung injury in primary human immune and airway epithelial cells Source: Virtual Congress 2021 – Emerging respiratory diseases: state-of-the-art studies of SARS-CoV-2 infection Year: 2021 Inhibition of IRAK4 suppresses chemokine release from human bronchial epithelial cells Source: Annual Congress 2013 –Molecular biology: state-of-the-art 2013 Year: 2013 Simvastatin selectively inhibits TSLP-production in primary bronchial epithelial cells from COPD donors Source: Annual Congress 2011 - Translational models of disease Year: 2011 LAS100977, a novel, selective, long-acting β2-agonist, improves airway conductance and reduces airway resistance in healthy subjects Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD Year: 2010 In vitro modulation of the cytokine-induced human bronchial epithelial cell (HBEC) functions by ciclesonide (CIC) Source: Eur Respir J 2004; 24: Suppl. 48, 346s Year: 2004 Platelet activating factor receptor (PAFr) expression is increased in airways of COPD patients but is not attenuated by inhaled corticosteroid (ICS) Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 The inhibitory activity of fluticasone propionate (FP) on human bronchial epithelial cell (HBECs) functions in vitro is related to the intensity of the target cell response to stimuli (FLIC 24) Source: Eur Respir J 2002; 20: Suppl. 38, 91s Year: 2002 Formoterol, but not salmeterol, restores corticosteroid sensitivity in peripheral blood mononuclear cells from COPD via PI3K inhibition Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD Year: 2008 Physiomer(R) reduces the chemokine interleukin-;8 production by activated human respiratory epithelial cells Source: Eur Respir J 2001; 18: 661-666 Year: 2001 Resveratrol impairs cytokine release from human airway smooth muscle cells (HASMCs) and alveolar macrophages (AM) in COPD Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009